361 related articles for article (PubMed ID: 11602899)
1. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.
Yao KA; Talamonti MS; Nemcek A; Angelos P; Chrisman H; Skarda J; Benson AB; Rao S; Joehl RJ
Surgery; 2001 Oct; 130(4):677-82; discussion 682-5. PubMed ID: 11602899
[TBL] [Abstract][Full Text] [Related]
2. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
5. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
6. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
10. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
Reddy SK; Barbas AS; Marroquin CE; Morse MA; Kuo PC; Clary BM
J Am Coll Surg; 2007 Mar; 204(3):372-82. PubMed ID: 17324770
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
Nissen NN; Kim AS; Yu R; Wolin EM; Friedman ML; Lo SK; Wachsman AM; Colquhoun SD
Am Surg; 2009 Oct; 75(10):1025-9. PubMed ID: 19886158
[TBL] [Abstract][Full Text] [Related]
12. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
[TBL] [Abstract][Full Text] [Related]
13. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
Christante D; Pommier S; Givi B; Pommier R
Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of malignant pancreatic islet cell tumors].
Egorov AV; Kuzin NM; Kondrashin SA; Lotov AN; Kazantseva IA; Kuznetsov NS; Gurevich LE; Lakreeva MG
Khirurgiia (Mosk); 2000; (5):13-7. PubMed ID: 10842959
[TBL] [Abstract][Full Text] [Related]
15. Combined resection of the liver and pancreas for malignancy.
Hemming AW; Magliocca JF; Fujita S; Kayler LK; Hochwald S; Zendejas I; Kim RD
J Am Coll Surg; 2010 May; 210(5):808-14, 814-6. PubMed ID: 20421055
[TBL] [Abstract][Full Text] [Related]
16. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
17. Aggressive surgery for metastatic liver neuroendocrine tumors.
Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
[TBL] [Abstract][Full Text] [Related]
18. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.
Yedibela S; Gohl J; Graz V; Pfaffenberger MK; Merkel S; Hohenberger W; Meyer T
Ann Surg Oncol; 2005 Oct; 12(10):778-85. PubMed ID: 16132374
[TBL] [Abstract][Full Text] [Related]
19. Aggressive surgery for liver metastases from gastrointestinal stromal tumors.
Shima Y; Horimi T; Ishikawa T; Ichikawa J; Okabayashi T; Nishioka Y; Hamada M; Shibuya Y; Ishii T; Ito M
J Hepatobiliary Pancreat Surg; 2003; 10(1):77-80. PubMed ID: 12827476
[TBL] [Abstract][Full Text] [Related]
20. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
Kobayashi K; Gupta S; Trent JC; Vauthey JN; Krishnamurthy S; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; McRae SE; Hicks ME
Cancer; 2006 Dec; 107(12):2833-41. PubMed ID: 17096432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
